REACH support
Registration status review, SVHC screening, exposure scenario alignment, and tonnage-band documentation for EU supply programs.
Regulated buyers need more than a material code. They need clear jurisdiction logic, consistent hazard communication, audit-ready document trails, and specialists who understand how fine chemical supply decisions affect registrations, customs, and release planning.

Lonza teams help quality, procurement, and regulatory groups assemble consistent evidence packages. Each track is scoped with clear assumptions: substance identity, intended use, annual tonnage, customer geography, and required language formats.
Registration status review, SVHC screening, exposure scenario alignment, and tonnage-band documentation for EU supply programs.
Inventory status checks, significant new use considerations, and customer-facing statements for United States manufacturing or import.
Turkey registration preparation, representative coordination, and translation-ready substance identity records.
Korean substance status, pre-registration evidence, and downstream use clarification for customer qualification files.
IECSC screening, new substance flagging, customs data consistency, and SDS localization support.
CSCL and ISHL considerations with controlled document responses for pharmaceutical and fine chemical supply chains.
Every regulatory engagement begins with intended market and application boundaries. A pharma intermediate used only under further synthesis may require a different evidence set than a fine chemical sold into a formulated product. Lonza keeps those distinctions visible so compliance language does not drift into unsupported claims.
| Region | Primary check | Typical output | Review trigger |
|---|---|---|---|
| EU | REACH EC 1907/2006 | Registration or exemption statement | Tonnage, use, SVHC update |
| US | TSCA inventory | Inventory status memo | New use, import route |
| Global | GHS SDS | Section 2 hazard communication | Formula, impurity, classification change |
| Customs | HS alignment | Classification support note | Route, purity, end-use shift |
Share the target region, molecule family, intended use, and current document need. Lonza will route the inquiry to a regulatory or quality contact who can explain the evidence path and the limits of any statement provided.